OxyContin TR Tablets Specified Drug Use-results Survey in patient with Chronic Pain

OxyContin TR Tablets Specified Drug Use-results Survey in patient with Chronic Pain - OxyContin TR Tablets Specified Drug Use-results Survey in patient with Chronic Pain

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042357

Enrollment

350

Registered

2020-11-05

Start date

2020-11-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who received OxyContin TR tablets for the first time to relieve chronic pain.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
(1) Safety evaluating drug dependency	—

Secondary

Measure	Time frame
(1) Safety Incidence rates of adverse drug reactions (2) Efficacy Clinical Global Impression-Improvement (CGI-I) Brief Pain Inventory-Severity of pain, funactional impairment	—

Countries

Japan

Contacts

Public ContactYoshinori Kitano

Shionogi Pharma Co., Ltd. Regulatory Affairs and Pharmacovigilance Department

yoshinori.kitano@shionogi.co.jp06-6381-7103

Outcome results